Skip to main content
Premium Trial:

Request an Annual Quote

Checkmarks in Both the 'Pro' and 'Con' Columns

The BBC speaks with 23andMe's Linda Avey and Anne Wojcicki about their company and their motivation. "The reason we started this company is that we really dramatically wanted to change healthcare," Wojcicki tells the BBC. Avey adds that they think that if people know their genetic information, they will take better care of themselves. The BBC also mentions that FDA is "warming to personal gene services," though the public still has some concerns.

The ETC Group is issuing a series of reports on "impact and implications of human genomics." Its first report, found here, focuses on direct-to-consumer testing and personalized medicine, concluding that "what's really happening is that consumers are being recruited to be research subjects. … They are paying out of their own pockets for the privilege, armed with little knowledge and even less control over the final use of their samples."

 

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.